265 research outputs found

    Psychological Factors Influencing Credit Card Usage of Employees in Colombo District, Sri Lanka

    Get PDF
    Credit card is one of the trending cashless transaction methods used worldwide with the advancement of technology. Records in Central Bank of Sri Lanka (CBSL) show the demand and the number of credit cards issued are increasing day by day due to different reasons. Researchers have revealed that different demographic, socio-economic and credit card attributes were reasons for use of credit cards among different types of credit card holders. But the influence of psychological factors is also a subject of considerable research. Therefore, the objective of this research is to identify the influential psychological factors on credit card usage of employees in the Colombo district. With the aid of different sampling techniques where necessary, 385 respondents were selected for the sample. Required data were collected through a structured questionnaire and psychological variables were measured by ten-point Likert Scale Statements. Multiple linear regression analysis was carried out with the aid of Minitab 20. Results of the study revealed that the perceived financial cost, user pattern, social status and attitudes are highly influential psychological factors while convenience and financial optimism have not significantly influenced the credit card usage of employees in the Colombo district. Future research is suggested to identify the influence of similar factors for other districts and commercial banks separately, and apply advanced analysis to identify the latent factors that affect credit card usage of employees in the Colombo district. DOI: http://doi.org/10.31357/fhss/vjhss.v07i02.0

    GREEN PRODUCTIVITY: AN APPROACH FOR SUSTAINABLE DEVELOPMENT OF AGRO-FORESTRY IN SRI LANKA.

    Get PDF
    The agricultural and forest resources in Sri Lanka are diminishing while thepopulation is still growing. Hence, designing of resource-efficient agroforestrysystems has considerable potential not only to improve forest andagricultural production but also to enhance and maintain overall productivityof sustainable small farm units. The different types of agro forestry systemsin the country are highly diverse and complex in characters and functions.However, the productivity of agro-forestry system and the role inenvironmental conservation are lower than their potential due to lack ofproper management practices. Green Productivity (GP) approach emphasizesthe sustainable development of agro-forestry systems enhancing productivityand using resources efficiently while protecting the environment.The paper attempts to discuss the concept, methodology, principle stage,implementation strategies and impact assessment of GP approach with theview of sustainable development of agro-forestry systems in Sri Lanka. TheGP concept emphasizes environmentally sound technology transfer to keepagro forestry systems competitive; environmental regulations to extendfarmers responsibility; and cleaner production enhancing productivity andenvironmental performance of the agro-forestry systems. The methodologyof GP would consist of problem-solving steps, selecting tools, techniques andtechnologies useful for solving problems in agro forestry and application ofsocio-economic and environmental principles and values for agro-forestryimprovements. The six principle stages of GP are described in terms ofgetting started to gain base-line information and identify problems in agroforestrysystems: generation and evaluation of GP options to meet theobjectives and targets of the agro-forestry system: implementation of GPoptions involving performance and the targets being achieved: and sustainingGP through corrective options to achieve objectives and targets of thesustainable agro forestry systems

    Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT.

    Get PDF
    BACKGROUND: Motivational interviewing (MI) enhanced with behaviour change techniques (BCTs) and deployed by health trainers targeting multiple risk factors for cardiovascular disease (CVD) may be more effective than interventions targeting a single risk factor. OBJECTIVES: The clinical effectiveness and cost-effectiveness of an enhanced lifestyle motivational interviewing intervention for patients at high risk of CVD in group settings versus individual settings and usual care (UC) in reducing weight and increasing physical activity (PA) were tested. DESIGN: This was a three-arm, single-blind, parallel randomised controlled trial. SETTING: A total of 135 general practices across all 12 South London Clinical Commissioning Groups were recruited. PARTICIPANTS: A total of 1742 participants aged 40-74 years with a ≥ 20.0% risk of a CVD event in the following 10 years were randomised. INTERVENTIONS: The intervention was designed to integrate MI and cognitive-behavioural therapy (CBT), delivered by trained healthy lifestyle facilitators in 10 sessions over 1 year, in group or individual format. The control group received UC. RANDOMISATION: Simple randomisation was used with computer-generated randomisation blocks. In each block, 10 participants were randomised to the group, individual or UC arm in a 4 : 3 : 3 ratio. Researchers were blind to the allocation. MAIN OUTCOME MEASURES: The primary outcomes are change in weight (kg) from baseline and change in PA (average number of steps per day over 1 week) from baseline at the 24-month follow-up, with an interim follow-up at 12 months. An economic evaluation estimates the relative cost-effectiveness of each intervention. Secondary outcomes include changes in low-density lipoprotein cholesterol and CVD risk score. RESULTS: The mean age of participants was 69.75 years (standard deviation 4.11 years), 85.5% were male and 89.4% were white. At the 24-month follow-up, the group and individual intervention arms were not more effective than UC in increasing PA [mean 70.05 steps, 95% confidence interval (CI) -288 to 147.9 steps, and mean 7.24 steps, 95% CI -224.01 to 238.5 steps, respectively] or in reducing weight (mean -0.03 kg, 95% CI -0.49 to 0.44 kg, and mean -0.42 kg, 95% CI -0.93 to 0.09 kg, respectively). At the 12-month follow-up, the group and individual intervention arms were not more effective than UC in increasing PA (mean 131.1 steps, 95% CI -85.28 to 347.48 steps, and mean 210.22 steps, 95% CI -19.46 to 439.91 steps, respectively), but there were reductions in weight for the group and individual intervention arms compared with UC (mean -0.52 kg, 95% CI -0.90 to -0.13 kg, and mean -0.55 kg, 95% CI -0.95 to -0.14 kg, respectively). The group intervention arm was not more effective than the individual intervention arm in improving outcomes at either follow-up point. The group and individual interventions were not cost-effective. CONCLUSIONS: Enhanced MI, in group or individual formats, targeted at members of the general population with high CVD risk is not effective in reducing weight or increasing PA compared with UC. Future work should focus on ensuring objective evidence of high competency in BCTs, identifying those with modifiable factors for CVD risk and improving engagement of patients and primary care. TRIAL REGISTRATION: Current Controlled Trials ISRCTN84864870. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 69. See the NIHR Journals Library website for further project information. This research was part-funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London

    Changes in attitudes to awareness of hypoglycaemia during a hypoglycaemia awareness restoration programme are associated with avoidance of further severe hypoglycaemia episodes within 24 months: the A2A in HypoCOMPaSS study

    Get PDF
    Aims/hypothesis: The aims of this study were to assess cognitions relating to hypoglycaemia in adults with type 1 diabetes and impaired awareness of hypoglycaemia before and after the multimodal HypoCOMPaSS intervention, and to determine cognitive predictors of incomplete response (one or more severe hypoglycaemic episodes over 24 months). Methods: This analysis included 91 adults with type 1 diabetes and impaired awareness of hypoglycaemia who completed the Attitudes to Awareness of Hypoglycaemia (A2A) questionnaire before, 24 weeks and 24 months after the intervention, which comprised a short psycho-educational programme with optimisation of insulin therapy and glucose monitoring. Results: The age and diabetes duration of the participants were 48±12 and 29±12 years, respectively (mean±SD). At baseline, 91% reported one or more severe hypoglycaemic episodes over the preceding 12 months; this decreased to <20% at 24 weeks and after 24 months (p=0.001). The attitudinal barrier hyperglycaemia avoidance prioritised (2p=0.250, p=0.001) decreased from baseline to 24 weeks, and this decrease was maintained at 24 months (mean±SD=5.3±0.3 vs 4.3±0.3 vs 4.0±0.3). The decrease in asymptomatic hypoglycaemia normalised from baseline (2p=0.113, p=0.045) was significant at 24 weeks (1.5±0.3 vs 0.8±0.2). Predictors of incomplete hypoglycaemia response (one or more further episodes of severe hypoglycaemia) were higher baseline rates of severe hypoglycaemia, higher baseline scores for asymptomatic hypoglycaemia normalised, reduced change in asymptomatic hypoglycaemia normalised scores at 24 weeks, and lower baseline hypoglycaemia concern minimised scores (all p<0.05). Conclusions/interpretation: Participation in the HypoCOMPaSS RCT was associated with improvements in hypoglycaemia-associated cognitions, with hyperglycaemia avoidance prioritised most prevalent. Incomplete prevention of subsequent severe hypoglycaemia episodes was associated with persistence of the cognition asymptomatic hypoglycaemia normalised. Understanding and addressing cognitive barriers to hypoglycaemia avoidance is important in individuals prone to severe hypoglycaemia episodes. Clinical trials registration: www.isrctn.org: ISRCTN52164803 and https://eudract.ema.europa.eu: EudraCT2009-015396-27. Graphical abstract: [Figure not available: see fulltext.]. (c) 2022, The Author(s)

    FitFlame – Health and Fitness Coaching Application to Mitigate the Issues in the Current Applications

    Get PDF
    Online fitness coaches help people achieve a healthy lifestyle by offering customized solutions. The demand for professional coaching is expected to grow in the coming years. Nevertheless, no applications in the market address the problems in the coaching process. Today, coaches and clients had to use many third-party apps. The reason for this is that no single fitness coaching app offers communication and exercise-tracking features. Even though some apps meet some of these requirements, they are out of reach for most people's budgets. This paper aims to suggest a robust and full-fledged app to mitigate those issues. FitFlame is the name of the proposed app. Both coaches and clients can benefit from this app. Also, FitFlame is a fitness coaching system available on mobile and the web. It helps clients locate and contact coaches, subscribe to coaching plans, and track their progress. It does away with third-party programs and gives users a better experience

    Design and Implementation of a Web Application for an E-Plant Store

    Get PDF
    With the advancement of technology in every industry, finding items with a few clicks is now simpler. Most people do not have enough knowledge about planting and its advantages of it. Therefore, this platform will be very helpful for those who sell and buy plants. Customers cannot compare prices or pay online when it comes to markets or plant nurseries. So, in this case, Plantae.lk offers various opportunities to customers. They can inspect, get details, compare plants’ pricing, and make online payments easily. In this competitive business world, customer satisfaction is extremely important. We want each customer to have a pleasant shopping experience. With that intention, customer support service offers technical advice and guidance when it is needed. This web application also consists of detailed gardening advice. The major goal of this web application is to provide a better business experience for both seller and consumer.([1])([2]

    Analysis of National Forest Programs for REDD+ Implementation in six South and Southeast Asia countries

    Get PDF
    Aim of study: To facilitate REDD+ implementation and identify relevant attributes for robust REDD+ policies, this study evaluated and synthesized information from national forest programs in South and Southeast Asian countries.Area of study: Data was collected from six countries: Sri Lanka, Indonesia, Bangladesh, Philippines, India and Thailand.Methods: The data sources for the evaluation was an in-depth desk review of relevant documents and focus group discussion among experts from each study country.  Main Results: We found out that diverse factors may influence program feasibility and the ability to achieve ‘triple benefits’: the nature of the forest targeted by the policy, the characteristics of the population affected by the policy, attributes of the policy instrument and the different actors involved.Research highlights: We argue that national policies and programs targeted for REDD+ implementation should focus on the identified features to achieve REDD+ goals.Keywords: policy evaluation; policy instruments; triple benefits; Southeast Asia

    Comparing the effectiveness of an enhanced MOtiVational intErviewing InTervention (MOVE IT) with usual care for reducing cardiovascular risk in high risk subjects: study protocol for a randomised controlled trial.

    Get PDF
    BACKGROUND: Interventions targeting multiple risk factors for cardiovascular disease (CVD), including poor diet and physical inactivity, are more effective than interventions targeting a single risk factor. A motivational interviewing (MI) intervention can provide modest dietary improvements and physical activity increases, while adding cognitive behaviour therapy (CBT) skills may enhance the effects of MI. We designed a randomised controlled trial (RCT) to examine whether specific behaviour change techniques integrating MI and CBT result in favourable changes in weight and physical activity in those at high risk of CVD. A group and individual intervention will be compared to usual care. A group intervention offers potential benefits from social support and may be more cost effective. METHODS/DESIGN: Individuals aged between 40 and 74 years in 11 South London Clinical Commissioning Groups who are at high risk of developing CVD (≥20%) in the next 10 years will be recruited. A sample of 1,704 participants will be randomised to receive the enhanced MI intervention, delivered by trained healthy lifestyle facilitators (HLFs), in group or individual formats, in 10 sessions (plus an introductory session) over one year, or usual care. Randomisation will be conducted by King's College London Clinical Trials Unit and researchers collecting outcome data will be blinded to treatment allocation. At 12-month and 24-month follow-up assessments, primary outcomes will be change in weight and physical activity (average steps per day). Secondary outcomes include changes in low-density lipoprotein cholesterol and CVD risk score. Incidence of CVD events since baseline will be recorded. A process evaluation will be conducted to evaluate factors which impact on delivery, adherence and outcome. An economic evaluation will estimate relative cost-effectiveness of each type of intervention delivery. DISCUSSION: This RCT assesses the effectiveness of a healthy lifestyle intervention for people at high risk of CVD. Benefits of the study include the ethnic and socioeconomic diversity of the study population and that, via social support within the group setting and long-term follow-up period, the intervention offers the potential to support maintenance of a healthy lifestyle. TRIAL REGISTRATION: This trial is registered with the ISRCTN registry (identifier: ISRCTN84864870, registered 15 May 2012)

    A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)

    Get PDF
    Impaired awareness of hypoglycaemia (IAH) is a major risk for severe hypoglycaemia in insulin treatment of type 1 diabetes (T1D). To explore the hypothesis that unhelpful health beliefs create barriers to regaining awareness, we conducted a multi-centre, randomised, parallel, two-arm trial (ClinicalTrials.gov NCT02940873) in adults with T1D and treatment-resistant IAH and severe hypoglycaemia, with blinded analysis of 12-month recall of severe hypoglycaemia at 12 and/or 24 months the primary outcome. Secondary outcomes included cognitive and emotional measures. Adults with T1D, IAH and severe hypoglycaemia despite structured education in insulin adjustment, +/− diabetes technologies, were randomised to the “Hypoglycaemia Awareness Restoration Programme despite optimised self-care” (HARPdoc, n = 49), a psychoeducation programme uniquely focussing on changing cognitive barriers to avoiding hypoglycaemia, or the evidence-based “Blood Glucose Awareness Training” (BGAT, n = 50), both delivered over six weeks. Median [IQR] severe hypoglycaemia at baseline was 5[2–12] per patient/year, 1[0–5] at 12 months and 0[0–2] at 24 months, with no superiority for HARPdoc (HARPdoc vs BGAT incident rate ratios [95% CI] 1.25[0.51, 3.09], p = 0.62 and 1.26[0.48, 3.35], p = 0.64 respectively), nor for changes in hypoglycaemia awareness scores or fear. Compared to BGAT, HARPdoc significantly reduced endorsement of unhelpful cognitions (Estimated Mean Difference for Attitudes to Awareness scores at 24 months, −2.07 [−3.37,−0.560], p = 0.01) and reduced scores for diabetes distress (−6.70[−12.50,−0.89], p = 0.02); depression (−1.86[−3.30, −0.43], p = 0.01) and anxiety (−1.89[−3.32, −0.47], p = 0.01). Despite positive impact on cognitive barriers around hypoglycaemia avoidance and on diabetes-related and general emotional distress scores, HARPdoc was not more effective than BGAT at reducing severe hypoglycaemia

    Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

    Get PDF
    OBJECTIVES: Cyclophosphamide induction regimens are effective for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but are associated with infections, malignancies and infertility. Mycophenolate mofetil (MMF) has shown high remission rates in small studies of AAV. METHODS: We conducted a randomised controlled trial to investigate whether MMF was non-inferior to cyclophosphamide for remission induction in AAV. 140 newly diagnosed patients were randomly assigned to MMF or pulsed cyclophosphamide. All patients received the same oral glucocorticoid regimen and were switched to azathioprine following remission. The primary endpoint was remission by 6 months requiring compliance with the tapering glucocorticoid regimen. Patients with an eGFR <15 mL/min were excluded from the study. RESULTS: At baseline, ANCA subtype, disease activity and organ involvement were similar between groups. Non-inferiority was demonstrated for the primary remission endpoint, which occurred in 47 patients (67%) in the MMF group and 43 patients (61%) in the cyclophosphamide group (risk difference 5.7%, 90% CI -7.5% to 19%). Following remission, more relapses occurred in the MMF group (23 patients, 33%) compared with the cyclophosphamide group (13 patients, 19%) (incidence rate ratio 1.97, 95% CI 0.96 to 4.23, p=0.049). In MPO-ANCA patients, relapses occurred in 12% of the cyclophosphamide group and 15% of the MMF group. In PR3-ANCA patients, relapses occurred in 24% of the cyclophosphamide group and 48% of the MMF group. Serious infections were similar between groups (26% MMF group, 17% cyclophosphamide group) (OR 1.67, 95% CI 0.68 to 4.19, p=0.3). CONCLUSION: MMF was non-inferior to cyclophosphamide for remission induction in AAV, but resulted in higher relapse rate. TRIAL REGISTRATION NUMBER: NCT00414128
    corecore